Avanos Medical, Inc. (AVNS)

In August 2025, Avanos Medical announced its Second Quarter results, appointed Scott Galovan as CFO, and David Pacitti to the Board. In September 2025, Avanos Medical acquired Nexus Medical. In October 2025, WRS Group acquired Avanos Medical's US Game Ready orthopedic rental business. In November 2025, the company announced its Third Quarter results. In January 2026, Avanos Medical and Siemens Healthineers collaborated to advance integrated solutions for pain management. In February 2026, short interest in Avanos Medical increased, and CMS maintained NOPAIN Act eligibility for ON-Q and ambIT Infusion Pumps and added Game Ready in 2026.

Specific detailed information regarding the demand seasonality for Avanos Medical, Inc.'s products and services is not readily available in the provided search results. While "AVNS Seasonality" is mentioned as a feature to identify seasonal patterns, accessing this data requires creating an account. Therefore, a comprehensive analysis of demand seasonality cannot be provided at this time.

Avanos Medical, Inc. is a U.S.-based medical technology company operating in the Healthcare sector, specifically in the Medical Devices industry. It focuses on delivering solutions in Pain Management and Chronic Care, aiming to reduce opioid use, accelerate patient recovery, and prevent infection. Its major products include Digestive Health Products, Non-Opioid Pain Solutions, Interventional Pain Solutions, and Respiratory Health Products. Avanos Medical markets its products directly to hospitals, healthcare providers, and other healthcare facilities, as well as through third-party wholesale distributors.

Avanos Medical has a significant global presence, providing medical device solutions across North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. The company sells its brands and products in over 90 countries and operates eight principal medical device production facilities, including locations in the United States and Mexico. It maintains offices in various countries, including the United Kingdom, Belgium, France, Netherlands, Sweden, Germany, Portugal, Japan, Singapore, Australia, and India.

Information specifically detailing events that have negatively or positively impacted Avanos Medical, Inc.'s brand reputation within the past year is limited in the provided search results. In July 2021, Avanos Medical Inc. agreed to pay over $22 million to resolve a criminal charge related to the fraudulent misbranding of its MicroCool surgical gowns. In February 2026, the Centers for Medicare and Medicaid Services (CMS) maintained NOPAIN Act eligibility for Avanos' ON-Q* and ambIT* Infusion Pumps and added Game Ready* in 2026, which could be seen as a positive for the brand's standing in pain management solutions.

Major institutional owners of Avanos Medical include BlackRock, Inc., T. Rowe Price Group, Inc., and The Vanguard Group, Inc. Individual insider ownership accounts for 2.13% of the company's shares. Recent insider transactions include buying by Gary Blackford in August 2025 and selling by Kerr Holbrook in November 2025.